News
Publications
All Publications
E-Books
Media
Editorial Podcasts
Editorial Videos
Sponsored Podcasts
Sponsored Videos
Conferences
Conference Coverage
Conference Listing
Columns
All Columns
A Closing Thought
Clinical Trial Insights
View from Brussels
View from Washington
Resources
Advertise
Blogs
Brand Insights
Events
Front & Center
Subscribe
White Papers
Webcasts
Choose Specialty
Analytics
CRO/Sponsor
Clinical Operations
Clinical Trial Supply Chain
DE&I
Data Management
EMA
Early Phase Development
Emerging Technology
Executive Roundtable
FDA
Feature Article
Industry Trends
Investigative Sites
Metrics and Benchmarks
Oncology
Online Extras
Patient Participation
Peer-Reviewed Articles
Protocol Design
Real World Evidence
Regulatory
Risk-Based Monitoring
Study Start-Up
Therapeutic Areas
Trial Design
Vendor Strategy & Collaboration
eClinical
mHealth
Spotlight -
Conference Coverage
CRO/Sponsor
DE&I
2023 Salary Survey
Choose Specialty
Analytics
CRO/Sponsor
Clinical Operations
Clinical Trial Supply Chain
DE&I
Data Management
EMA
Early Phase Development
Emerging Technology
Executive Roundtable
FDA
Feature Article
Industry Trends
Investigative Sites
Metrics and Benchmarks
Oncology
Online Extras
Patient Participation
Peer-Reviewed Articles
Protocol Design
Real World Evidence
Regulatory
Risk-Based Monitoring
Study Start-Up
Therapeutic Areas
Trial Design
Vendor Strategy & Collaboration
eClinical
mHealth
Spotlight
News
Publications
Media
Conferences
Columns
Resources
Webcasts
Advertisement
Emily Akin, Research Network Lead, Flatiron Health
home
/ authors
/ emily-akin-research-network-lead-flatiron-health
Articles
Advertisement
Benefits of delegating the patient screening process for oncology trials
December 20th 2023
